Review on Atherogenic Index of Plasma Lipids and Dyslipidemia
Abstract
Dyslipidemia is defined as abnormally levels of lipids in the blood. Different types of lipids and lipoproteins have been identified. Dyslipidemia is a single strong risk factor for the development of cardiovascular events and atherosclerosis is the most common. It has been described as a disease of the economically advanced societies, but recently, it has found its way into the semi-urban societies and among its dwellers, who are at the increasing risk of developing cardiovascular accidents. Hence, early identification and diagnosis of dyslipidemia at its earliest stage among this populace is a worthwhile cardiovascular preventive measure. The study of hyperlipidaemia is of considerable importance, mainly because of the involvement of lipids in cardiovascular diseases. The classification system of hyperlipidaemia is based on which plasma lipoprotein concentrations were increased. Fredrickson classification helped to put lipidology on the clinical map, though it was not a diagnostic classification. It gives little clue as to the aetiology of the disorder. Currently, a more descriptive classification is used for the primary hyperlipidaemia although they can be genetic or secondary factors. This review presents the overview of plasma lipids. This article illustrates the theoretical background and details about dyslipidemias.
Keywords: Dyslipidemia, Atherogenic index, Hyperlipidaemia, Atherosclerosis, Lipoproteins
Keywords:
Dyslipidemia, Atherogenic index, Hyperlipidaemia, Atherosclerosis, LipoproteinsDOI
https://doi.org/10.22270/jddt.v12i4-S.5477References
Uchendu IK, Ekeigwe IB, Nnedu EB. Antidyslipidaemic and cardioprotective effects of turmeric (Curcuma longa) in rat fed a high cholesterol diet. Journal of Drug Delivery and Therapeutics, 2020; 15; 10(1-s):178-81. https://doi.org/10.22270/jddt.v10i1-s.3869
Eriksson JG, Forsen T, Tuomilehto J, Osmond C, Barker DJ. Early growth and coronary heart disease in later life: longitudinal study. British medical journal 2001, 21; 322(7292):949-53. https://doi.org/10.1136/bmj.322.7292.949
Uchendu IK, Onwukwe SO, Agu CE, Orji CO, Eluke BC, Nwosu TF. Hypolipidaemic and renoprotective effects of Glycine max (soy bean) against lipid profile and renal biochemical alterations in hypercholesterolemic rat. International Journal of Biomedical Research. 2016; 7:822-828.
Collabero B. Obesity in developing countries- Biological and ecological factors. Symposium Journal of nutrition supplement 2001; 131:866-870.
Silver I, Nyerhovwo, JT. The influence of dietary intake on the serum lipid profile, body mass and risk of cardiovascular disease in adults on the Niger Delta region. Journal of nutrition and metabolism 2010; 2(3):40-44.
Martin AC. Plasma lipids and lipoproteins: In Clinical biochemistry and metabolic medicine, 8th Edition.2012, 210-225.
Bach DW. (2010). Phospholipids/ cholesterol model membrans. Formation of cholesterol crystallates. Biochemica et biophysica Acta, 2010, 1610(2): 187-197. https://doi.org/10.1016/S0005-2736(03)00017-8
Nader R, Warnick, RG, Remaley TA. Lipids, lipoprotein, apolipoprotein and other cardiac risk factors: In Tietz fundamental of clinical chemistry and molecular diagnostics. Burtis, C. A. and Bruns (Editors), 5th Edition. 2015, 388-411.
Dinasarapu AR, Saunders B, Ozerlat I. Azam K, Subramaniam S. Signalling gateway molecules pages - a data model perspective. Bioinformatives 2011; 27(12):1736-1738. https://doi.org/10.1093/bioinformatics/btr190
Klein C, Malviya, AN. Mechanism of nuclear calcium signalling by inositol 1, 4, 5-triphosphate produced in the nucleus, nuclear located protein kinase C and cyclic AMP dependent protein kinase. Frontiers in Bioscience 2008; 13(13):1206-1226. https://doi.org/10.2741/2756
Fezza F, De simone, C, Amadio D, Maccarone. Fatty acids amide hydrolase: a gatekeeper of the endocannabinoid system. Subcellular biochemistry 2008; 49:101-132. https://doi.org/10.1007/978-1-4020-8831-5_4
Honke K, Zhang Y, Cheng X, Kotani N, Taniguchi N. Biological roles of sulfoglycolipids and pathophysiology of their deficiency. Glycoconjugate Journal 2009; 21(1-2):59-62. https://doi.org/10.1023/B:GLYC.0000043749.06556.3d
Segre D, Ben-Eli D, Deamer DW, Lancet D. The lipid world. Origins of life and evolution of the biosphere 2001; 31(1-2):119-145. https://doi.org/10.1023/A:1006746807104
Walsh CT. Polyketide and non-ribosomal peptide antibiotics. Modularity and versatility science 2009; 303(5665):1805-1810. https://doi.org/10.1126/science.1094318
Yashroy RC. 13C NMR studies of lipid fatty acyl chains of chloroplast membrane. Indian Journal of Biochemistry 2007; 24(6):177-178.
Eyster KM. The membrane and lipids as integral participants in signal transduction: lipid signal transduction for the non-lipid biochemistry. Advances in physiology Education 2007; 31(1):5-16. https://doi.org/10.1152/advan.00088.2006
Hunter JE. Dietary trans fatty acids: review of recent human studies and food industry responses. Lipids 2010; 41(11):967-992. https://doi.org/10.1007/s11745-006-5049-y
Parks EJ. Dietary carbohydrates effects on lipogenesis and the relationship of lipogenesis to blood insulin and glucose concentration. British Journal of Nutrition 2002; 87:5247-5453. https://doi.org/10.1079/BJN/2002544
Sembulingam K, Sembulingam P. Digestion, absorption and metabolism of lipids: In Essentials of medical physiology. JP Medical Ltd; 2012, 292-301. https://doi.org/10.5005/jp/books/11696_125
Karam I, Yang YJ, Li JY. Hyperlipidemia background and progress. SM Atherosclerosis Journal 2017; 1(1):1003.
Raman M, Almutairdi A, Mulesa L, Alberda C, Beattie C, Gramlich L. Parenteral nutrition and lipids. Nutrients. 2017; 9(4):388. https://doi.org/10.3390/nu9040388
Tomkin GH, Owens D. LDL as a cause of atherosclerosis. The Open Atherosclerosis and Thrombosis Journal, 2012; 5:13-21. https://doi.org/10.2174/1876506801205010013
Arun B, Budha R, Jones E. Relationship between anthropometric measurements, atherogenic index of plasma and lipid profile among the healthy adults from an urban area. National Journal of Basic Medical Sciences 2015; 5 (3):74-77.
Aziz M, Yadav KS. Pathogenesis of atherosclerosis: A review. Medical and Clinical Review 2016; 2(3):1-6. https://doi.org/10.21767/2471-299X.1000031
Kuo TP. Dyslipidaemia and coronary artery disease. Clinical cardiology 1994; 17:519-527. https://doi.org/10.1002/clc.4960171003
Lily L. Pathophysiology of Heart Disease; A collaborative project of medical students and faculty. 3rd Edition. Lippincott Williams and Willns, Philadelphia. 2003, 133-144.
Van Epps J, Vorp D. Mechano-pathobiology of atherosclerosis. Journal of Surgical Research 2006, 142:202-217. https://doi.org/10.1016/j.jss.2006.11.001
Glass C, Witztum J. Atherosclerosis: The road ahead. Cell 2001; 104: 503-516. https://doi.org/10.1016/S0092-8674(01)00238-0
Gonzalez MA, Selwyn AP. Endothelial function, inflammation and prognosis in cardiovascular disease. American Journal of Medicine 2003; 115:99-106. https://doi.org/10.1016/j.amjmed.2003.09.016
National Cholesterol Education Programme. Detection, evaluation and treatment of high blood cholesterol in adults (adult panel III). Journal of American Medical Association 2002; 285:2486- 2497. https://doi.org/10.1001/jama.285.19.2486
Cullen P, Rauterberg J, Lorkowski S. The pathogenesis of atherosclerosis. Handbook of Experimental Pharmacology 2005; 170:3-70. https://doi.org/10.1007/3-540-27661-0_1
Lorkowski S, Cullen P. Atherosclerosis: pathogenesis, clinical feature and treatment. Encyclopedia of life sciences 2007; 1-11. https://doi.org/10.1002/9780470015902.a0004228
Olamoyegun MA, Oluyombo R, Olabode AS. Evaluation of dyslipidaemia, lipid ratio and atherogenic index as cardiovascular risk factors among semi-urban dwellers in Nigeria. Annals of African Medicine 2016; 15 (4):194-199. https://doi.org/10.4103/1596-3519.194280
Published
Abstract Display: 1247
PDF Downloads: 571
PDF Downloads: 59 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

.